HK2 and breast cancer: Our research found that let-7b-5p is a novel inhibitor of HK2, inhibits HK enzyme activity, glucose uptake, lactate level, and ATP concentration, and leads to conversion from aerobic glycolysis to mitochondrial respiration via repressing HK2 in BC cells.